RGAHX
Price
$73.85
Change
-$9.79 (-11.70%)
Updated
Dec 18 closing price
STCAX
Price
$15.47
Change
-$0.51 (-3.19%)
Updated
Dec 18 closing price
Ad is loading...

RGAHX vs STCAX

Header iconRGAHX vs STCAX Comparison
Open Charts RGAHX vs STCAXBanner chart's image
American Funds Growth Fund of Amer R5E
Price$73.85
Change-$9.79 (-11.70%)
VolumeN/A
CapitalizationN/A
Virtus Silvant Large-Cap Growth Stk I
Price$15.47
Change-$0.51 (-3.19%)
VolumeN/A
CapitalizationN/A
RGAHX vs STCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGAHX vs. STCAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAHX is a Buy and STCAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 313B vs. STCAX (213M). RGAHX pays higher dividends than STCAX: RGAHX (0.64) vs STCAX (0.00). RGAHX was incepted earlier than STCAX: RGAHX (9 years) vs STCAX (32 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. STCAX (17.00). RGAHX has a lower initial minimum investment than STCAX: RGAHX (250) vs STCAX (100000). RGAHX (35.52) and STCAX (35.13) have marching annual gain over last year. STCAX return over 5 years is better than : 87.38 vs. RGAHX (56.03).
RGAHXSTCAXRGAHX / STCAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years32 years-
Gain YTD34.14636.97792%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets313B213M146,948%
Annual Yield % from dividends0.640.00-
Returns for 1 year35.5235.13101%
Returns for 3 years18.8633.4456%
Returns for 5 years56.0387.3864%
Returns for 10 yearsN/A63.34-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INUV0.380.03
+8.42%
Inuvo
DOMO7.690.28
+3.78%
Domo
ELP6.090.16
+2.70%
Companhia Paranaense de Energia - COPEL
ANIP55.83-0.53
-0.94%
ANI Pharmaceuticals
COF181.18-3.93
-2.12%
Capital One Financial